Clinical Trial: A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase III Study of A01016 125μg Intravitreal Injection in Subjects With Symptomatic Vitreomacular Adhesion - Comparison Study to Sham Injection
Brief Summary: The purpose of this study is to evaluate the superiority regarding vitreomacular adhesion (VMA) resolution of a single intravitreal injection of A01016 (Ocriplasmin) compared to sham-injection in subjects with symptomatic VMA.
Detailed Summary:
Sponsor: Alcon Research
Current Primary Outcome: Proportion of Subjects With Non-Surgical Resolution of Vitreomacular Adhesion (VMA) [ Time Frame: Day 28 ]
Original Primary Outcome: Proportion of Subjects with Non-Surgical Resolution of Vitreomacular Adhesion [ Time Frame: Day 28 ]
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Alcon Research
Dates:
Date Received: June 26, 2013
Date Started: July 2013
Date Completion:
Last Updated: November 2, 2015
Last Verified: November 2015